Continuous glucose monitoring reveals distinct clinical implications of glucose levels at the start and end of hemodialysis in people with type 2 diabetes

Key Points

• This research aims to explore the significance of glucose levels at the beginning and end of hemodialysis sessions in people with type 2 diabetes.
• Continuous glucose monitoring during hemodialysis sessions
• Comparison of glucose levels at the start and end of HD
• Assessment of hypoglycemia risk based on end-of-HD glucose levels
• End-of-HD glucose level is a strong indicator of hypoglycemia risk
• Distinct clinical relevance of glucose levels at different session phases was established
• Tailored monitoring strategies may improve glycemic risk assessment

Abstract